Immunotherapies and targeted therapies have led to significant strides in the treatment of patients with melanoma. However, determining which therapies are best for which patients and how to treat patients who don’t respond or stop responding to these new therapies is still a challenge. For further insight on optimizing the recent treatment breakthroughs in melanoma, OncLive spoke with Alan Bryce, MD, medical director of the Genomic Oncology Clinic at Mayo Clinic.
MRV Research
Scibase Supports the Physicians at the Karolinska University Hospital During the Euromelanoma Week
SciBase, that develops and markets a new method for the early detection of malignant melanoma, will today be present on-site at the Karolinska University Hospital to support the physicians in the detection of malignant melanoma.
Novel Anti-Melanoma Antibiotic-Based Strategy Identified in New Study
A research team at the Roswell Park Cancer Institute in Buffalo found that a previously identified antibiotic has anti-melanoma activity. The study entitled “Pharmacological targeting of guanosine monophosphate synthase suppresses melanoma cell invasion and tumorigenicity” was published in the journal Cell Death and Differentiation. This research was supported by the Jennifer Linscott Tietgen Family Foundation, which is dedicated to supporting melanoma cancer research in memory of their daughter, Jennifer.
Teenage Acne Linked with Increased Melanoma Risk
Having a history of teenage acne is associated with an increased risk of melanoma, independent of known risk factors, according to a study published in Cancer.